ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global IL-1 Receptor Antagonist Market Research Report 2025
Published Date: 2025-12-23
|
Report Code: QYRE-Auto-19N18137
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global IL 23 Receptor Antagonist Market Research Report 2024
BUY CHAPTERS

Global IL-1 Receptor Antagonist Market Research Report 2025

Code: QYRE-Auto-19N18137
Report
2025-12-23
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
SOBI
Kiniksa Pharmaceuticals
Boehringer Ingelheim Pharmaceuticals

IL-1 Receptor Antagonist Market

The global market for IL-1 Receptor Antagonist was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The IL-1 receptor antagonist (IL-1RA) is a protein that inhibits the effects of interleukin-1 (IL-1),a key mediator of inflammation.IL-1RA works by competitively binding to IL-1 receptors,thereby preventing IL-1 from initiating signaling cascades that promote inflammation and immune responses.In clinical settings,IL-1RA has been utilized as a therapeutic agent to manage inflammatory conditions such as rheumatoid arthritis and other autoinflammatory diseases.
North American market for IL-1 Receptor Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for IL-1 Receptor Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of IL-1 Receptor Antagonist include Novartis, Sobi, Kiniksa Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for IL-1 Receptor Antagonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IL-1 Receptor Antagonist.
The IL-1 Receptor Antagonist market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global IL-1 Receptor Antagonist market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IL-1 Receptor Antagonist manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of IL-1 Receptor Antagonist Market Report

Report Metric Details
Report Name IL-1 Receptor Antagonist Market
Segment by Type
  • Canakinumab
  • Anakinra
  • Rilonacept
  • Spesolimab
  • Other
Segment by Application
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Sobi, Kiniksa Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of IL-1 Receptor Antagonist manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of IL-1 Receptor Antagonist in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the IL-1 Receptor Antagonist Market report?

Ans: The main players in the IL-1 Receptor Antagonist Market are Novartis, Sobi, Kiniksa Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals

What are the Application segmentation covered in the IL-1 Receptor Antagonist Market report?

Ans: The Applications covered in the IL-1 Receptor Antagonist Market report are Hospital and Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the IL-1 Receptor Antagonist Market report?

Ans: The Types covered in the IL-1 Receptor Antagonist Market report are Canakinumab, Anakinra, Rilonacept, Spesolimab, Other

1 IL-1 Receptor Antagonist Market Overview
1.1 Product Definition
1.2 IL-1 Receptor Antagonist by Type
1.2.1 Global IL-1 Receptor Antagonist Market Value Comparison by Type (2024 VS 2031)
1.2.2 Canakinumab
1.2.3 Anakinra
1.2.4 Rilonacept
1.2.5 Spesolimab
1.2.6 Other
1.3 IL-1 Receptor Antagonist by Application
1.3.1 Global IL-1 Receptor Antagonist Market Value by Application (2024 VS 2031)
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global IL-1 Receptor Antagonist Market Size Estimates and Forecasts
1.4.1 Global IL-1 Receptor Antagonist Revenue 2020-2031
1.4.2 Global IL-1 Receptor Antagonist Sales 2020-2031
1.4.3 Global IL-1 Receptor Antagonist Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 IL-1 Receptor Antagonist Market Competition by Manufacturers
2.1 Global IL-1 Receptor Antagonist Sales Market Share by Manufacturers (2020-2025)
2.2 Global IL-1 Receptor Antagonist Revenue Market Share by Manufacturers (2020-2025)
2.3 Global IL-1 Receptor Antagonist Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of IL-1 Receptor Antagonist, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of IL-1 Receptor Antagonist, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of IL-1 Receptor Antagonist, Product Type & Application
2.7 Global Key Manufacturers of IL-1 Receptor Antagonist, Date of Enter into This Industry
2.8 Global IL-1 Receptor Antagonist Market Competitive Situation and Trends
2.8.1 Global IL-1 Receptor Antagonist Market Concentration Rate
2.8.2 The Global 5 and 10 Largest IL-1 Receptor Antagonist Players Market Share by Revenue
2.8.3 Global IL-1 Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global IL-1 Receptor Antagonist Market Scenario by Region
3.1 Global IL-1 Receptor Antagonist Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global IL-1 Receptor Antagonist Sales by Region: 2020-2031
3.2.1 Global IL-1 Receptor Antagonist Sales by Region: 2020-2025
3.2.2 Global IL-1 Receptor Antagonist Sales by Region: 2026-2031
3.3 Global IL-1 Receptor Antagonist Revenue by Region: 2020-2031
3.3.1 Global IL-1 Receptor Antagonist Revenue by Region: 2020-2025
3.3.2 Global IL-1 Receptor Antagonist Revenue by Region: 2026-2031
3.4 North America IL-1 Receptor Antagonist Market Facts & Figures by Country
3.4.1 North America IL-1 Receptor Antagonist Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America IL-1 Receptor Antagonist Sales by Country (2020-2031)
3.4.3 North America IL-1 Receptor Antagonist Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe IL-1 Receptor Antagonist Market Facts & Figures by Country
3.5.1 Europe IL-1 Receptor Antagonist Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe IL-1 Receptor Antagonist Sales by Country (2020-2031)
3.5.3 Europe IL-1 Receptor Antagonist Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IL-1 Receptor Antagonist Market Facts & Figures by Region
3.6.1 Asia Pacific IL-1 Receptor Antagonist Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific IL-1 Receptor Antagonist Sales by Region (2020-2031)
3.6.3 Asia Pacific IL-1 Receptor Antagonist Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America IL-1 Receptor Antagonist Market Facts & Figures by Country
3.7.1 Latin America IL-1 Receptor Antagonist Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America IL-1 Receptor Antagonist Sales by Country (2020-2031)
3.7.3 Latin America IL-1 Receptor Antagonist Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa IL-1 Receptor Antagonist Market Facts & Figures by Country
3.8.1 Middle East and Africa IL-1 Receptor Antagonist Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa IL-1 Receptor Antagonist Sales by Country (2020-2031)
3.8.3 Middle East and Africa IL-1 Receptor Antagonist Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IL-1 Receptor Antagonist Sales by Type (2020-2031)
4.1.1 Global IL-1 Receptor Antagonist Sales by Type (2020-2025)
4.1.2 Global IL-1 Receptor Antagonist Sales by Type (2026-2031)
4.1.3 Global IL-1 Receptor Antagonist Sales Market Share by Type (2020-2031)
4.2 Global IL-1 Receptor Antagonist Revenue by Type (2020-2031)
4.2.1 Global IL-1 Receptor Antagonist Revenue by Type (2020-2025)
4.2.2 Global IL-1 Receptor Antagonist Revenue by Type (2026-2031)
4.2.3 Global IL-1 Receptor Antagonist Revenue Market Share by Type (2020-2031)
4.3 Global IL-1 Receptor Antagonist Price by Type (2020-2031)
5 Segment by Application
5.1 Global IL-1 Receptor Antagonist Sales by Application (2020-2031)
5.1.1 Global IL-1 Receptor Antagonist Sales by Application (2020-2025)
5.1.2 Global IL-1 Receptor Antagonist Sales by Application (2026-2031)
5.1.3 Global IL-1 Receptor Antagonist Sales Market Share by Application (2020-2031)
5.2 Global IL-1 Receptor Antagonist Revenue by Application (2020-2031)
5.2.1 Global IL-1 Receptor Antagonist Revenue by Application (2020-2025)
5.2.2 Global IL-1 Receptor Antagonist Revenue by Application (2026-2031)
5.2.3 Global IL-1 Receptor Antagonist Revenue Market Share by Application (2020-2031)
5.3 Global IL-1 Receptor Antagonist Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis IL-1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis IL-1 Receptor Antagonist Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Sobi
6.2.1 Sobi Company Information
6.2.2 Sobi Description and Business Overview
6.2.3 Sobi IL-1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sobi IL-1 Receptor Antagonist Product Portfolio
6.2.5 Sobi Recent Developments/Updates
6.3 Kiniksa Pharmaceuticals
6.3.1 Kiniksa Pharmaceuticals Company Information
6.3.2 Kiniksa Pharmaceuticals Description and Business Overview
6.3.3 Kiniksa Pharmaceuticals IL-1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Kiniksa Pharmaceuticals IL-1 Receptor Antagonist Product Portfolio
6.3.5 Kiniksa Pharmaceuticals Recent Developments/Updates
6.4 Boehringer Ingelheim Pharmaceuticals
6.4.1 Boehringer Ingelheim Pharmaceuticals Company Information
6.4.2 Boehringer Ingelheim Pharmaceuticals Description and Business Overview
6.4.3 Boehringer Ingelheim Pharmaceuticals IL-1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Boehringer Ingelheim Pharmaceuticals IL-1 Receptor Antagonist Product Portfolio
6.4.5 Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IL-1 Receptor Antagonist Industry Chain Analysis
7.2 IL-1 Receptor Antagonist Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IL-1 Receptor Antagonist Production Mode & Process Analysis
7.4 IL-1 Receptor Antagonist Sales and Marketing
7.4.1 IL-1 Receptor Antagonist Sales Channels
7.4.2 IL-1 Receptor Antagonist Distributors
7.5 IL-1 Receptor Antagonist Customer Analysis
8 IL-1 Receptor Antagonist Market Dynamics
8.1 IL-1 Receptor Antagonist Industry Trends
8.2 IL-1 Receptor Antagonist Market Drivers
8.3 IL-1 Receptor Antagonist Market Challenges
8.4 IL-1 Receptor Antagonist Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
SOBI
Kiniksa Pharmaceuticals
Boehringer Ingelheim Pharmaceuticals
List of Tables
 Table 1. Global IL-1 Receptor Antagonist Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global IL-1 Receptor Antagonist Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global IL-1 Receptor Antagonist Market Competitive Situation by Manufacturers in 2024
 Table 4. Global IL-1 Receptor Antagonist Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global IL-1 Receptor Antagonist Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global IL-1 Receptor Antagonist Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global IL-1 Receptor Antagonist Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market IL-1 Receptor Antagonist Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of IL-1 Receptor Antagonist, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of IL-1 Receptor Antagonist, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of IL-1 Receptor Antagonist, Product Type & Application
 Table 12. Global Key Manufacturers of IL-1 Receptor Antagonist, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global IL-1 Receptor Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IL-1 Receptor Antagonist as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global IL-1 Receptor Antagonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global IL-1 Receptor Antagonist Sales by Region (2020-2025) & (K Units)
 Table 18. Global IL-1 Receptor Antagonist Sales Market Share by Region (2020-2025)
 Table 19. Global IL-1 Receptor Antagonist Sales by Region (2026-2031) & (K Units)
 Table 20. Global IL-1 Receptor Antagonist Sales Market Share by Region (2026-2031)
 Table 21. Global IL-1 Receptor Antagonist Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global IL-1 Receptor Antagonist Revenue Market Share by Region (2020-2025)
 Table 23. Global IL-1 Receptor Antagonist Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global IL-1 Receptor Antagonist Revenue Market Share by Region (2026-2031)
 Table 25. North America IL-1 Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America IL-1 Receptor Antagonist Sales by Country (2020-2025) & (K Units)
 Table 27. North America IL-1 Receptor Antagonist Sales by Country (2026-2031) & (K Units)
 Table 28. North America IL-1 Receptor Antagonist Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America IL-1 Receptor Antagonist Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe IL-1 Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe IL-1 Receptor Antagonist Sales by Country (2020-2025) & (K Units)
 Table 32. Europe IL-1 Receptor Antagonist Sales by Country (2026-2031) & (K Units)
 Table 33. Europe IL-1 Receptor Antagonist Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe IL-1 Receptor Antagonist Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific IL-1 Receptor Antagonist Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific IL-1 Receptor Antagonist Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific IL-1 Receptor Antagonist Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific IL-1 Receptor Antagonist Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific IL-1 Receptor Antagonist Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America IL-1 Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America IL-1 Receptor Antagonist Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America IL-1 Receptor Antagonist Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America IL-1 Receptor Antagonist Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America IL-1 Receptor Antagonist Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa IL-1 Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa IL-1 Receptor Antagonist Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa IL-1 Receptor Antagonist Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa IL-1 Receptor Antagonist Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa IL-1 Receptor Antagonist Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global IL-1 Receptor Antagonist Sales (K Units) by Type (2020-2025)
 Table 51. Global IL-1 Receptor Antagonist Sales (K Units) by Type (2026-2031)
 Table 52. Global IL-1 Receptor Antagonist Sales Market Share by Type (2020-2025)
 Table 53. Global IL-1 Receptor Antagonist Sales Market Share by Type (2026-2031)
 Table 54. Global IL-1 Receptor Antagonist Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global IL-1 Receptor Antagonist Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global IL-1 Receptor Antagonist Revenue Market Share by Type (2020-2025)
 Table 57. Global IL-1 Receptor Antagonist Revenue Market Share by Type (2026-2031)
 Table 58. Global IL-1 Receptor Antagonist Price (US$/Unit) by Type (2020-2025)
 Table 59. Global IL-1 Receptor Antagonist Price (US$/Unit) by Type (2026-2031)
 Table 60. Global IL-1 Receptor Antagonist Sales (K Units) by Application (2020-2025)
 Table 61. Global IL-1 Receptor Antagonist Sales (K Units) by Application (2026-2031)
 Table 62. Global IL-1 Receptor Antagonist Sales Market Share by Application (2020-2025)
 Table 63. Global IL-1 Receptor Antagonist Sales Market Share by Application (2026-2031)
 Table 64. Global IL-1 Receptor Antagonist Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global IL-1 Receptor Antagonist Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global IL-1 Receptor Antagonist Revenue Market Share by Application (2020-2025)
 Table 67. Global IL-1 Receptor Antagonist Revenue Market Share by Application (2026-2031)
 Table 68. Global IL-1 Receptor Antagonist Price (US$/Unit) by Application (2020-2025)
 Table 69. Global IL-1 Receptor Antagonist Price (US$/Unit) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis IL-1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis IL-1 Receptor Antagonist Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Sobi Company Information
 Table 76. Sobi Description and Business Overview
 Table 77. Sobi IL-1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sobi IL-1 Receptor Antagonist Product
 Table 79. Sobi Recent Developments/Updates
 Table 80. Kiniksa Pharmaceuticals Company Information
 Table 81. Kiniksa Pharmaceuticals Description and Business Overview
 Table 82. Kiniksa Pharmaceuticals IL-1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Kiniksa Pharmaceuticals IL-1 Receptor Antagonist Product
 Table 84. Kiniksa Pharmaceuticals Recent Developments/Updates
 Table 85. Boehringer Ingelheim Pharmaceuticals Company Information
 Table 86. Boehringer Ingelheim Pharmaceuticals Description and Business Overview
 Table 87. Boehringer Ingelheim Pharmaceuticals IL-1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Boehringer Ingelheim Pharmaceuticals IL-1 Receptor Antagonist Product
 Table 89. Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. IL-1 Receptor Antagonist Distributors List
 Table 93. IL-1 Receptor Antagonist Customers List
 Table 94. IL-1 Receptor Antagonist Market Trends
 Table 95. IL-1 Receptor Antagonist Market Drivers
 Table 96. IL-1 Receptor Antagonist Market Challenges
 Table 97. IL-1 Receptor Antagonist Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of IL-1 Receptor Antagonist
 Figure 2. Global IL-1 Receptor Antagonist Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global IL-1 Receptor Antagonist Market Share by Type: 2024 & 2031
 Figure 4. Canakinumab Product Picture
 Figure 5. Anakinra Product Picture
 Figure 6. Rilonacept Product Picture
 Figure 7. Spesolimab Product Picture
 Figure 8. Other Product Picture
 Figure 9. Global IL-1 Receptor Antagonist Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global IL-1 Receptor Antagonist Market Share by Application: 2024 & 2031
 Figure 11. Hospital and Clinic
 Figure 12. Retail Pharmacies
 Figure 13. Other
 Figure 14. Global IL-1 Receptor Antagonist Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global IL-1 Receptor Antagonist Market Size (2020-2031) & (US$ Million)
 Figure 16. Global IL-1 Receptor Antagonist Sales (2020-2031) & (K Units)
 Figure 17. Global IL-1 Receptor Antagonist Average Price (US$/Unit) & (2020-2031)
 Figure 18. IL-1 Receptor Antagonist Report Years Considered
 Figure 19. IL-1 Receptor Antagonist Sales Share by Manufacturers in 2024
 Figure 20. Global IL-1 Receptor Antagonist Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest IL-1 Receptor Antagonist Players: Market Share by Revenue in IL-1 Receptor Antagonist in 2024
 Figure 22. IL-1 Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global IL-1 Receptor Antagonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America IL-1 Receptor Antagonist Sales Market Share by Country (2020-2031)
 Figure 25. North America IL-1 Receptor Antagonist Revenue Market Share by Country (2020-2031)
 Figure 26. United States IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe IL-1 Receptor Antagonist Sales Market Share by Country (2020-2031)
 Figure 29. Europe IL-1 Receptor Antagonist Revenue Market Share by Country (2020-2031)
 Figure 30. Germany IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific IL-1 Receptor Antagonist Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific IL-1 Receptor Antagonist Revenue Market Share by Region (2020-2031)
 Figure 37. China IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America IL-1 Receptor Antagonist Sales Market Share by Country (2020-2031)
 Figure 45. Latin America IL-1 Receptor Antagonist Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Colombia IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa IL-1 Receptor Antagonist Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa IL-1 Receptor Antagonist Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE IL-1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of IL-1 Receptor Antagonist by Type (2020-2031)
 Figure 56. Global Revenue Market Share of IL-1 Receptor Antagonist by Type (2020-2031)
 Figure 57. Global IL-1 Receptor Antagonist Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of IL-1 Receptor Antagonist by Application (2020-2031)
 Figure 59. Global Revenue Market Share of IL-1 Receptor Antagonist by Application (2020-2031)
 Figure 60. Global IL-1 Receptor Antagonist Price (US$/Unit) by Application (2020-2031)
 Figure 61. IL-1 Receptor Antagonist Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Interleukin Inhibitors for Psoriasis Market Research Report 2024
Global IL 23p19 Inhibitors Market Research Report 2024
Global IL 2R Inhibitors Market Research Report 2024
Global IL 17 Inhibitors for Psoriasis Market Research Report 2024
Global IL 6R Inhibitor Market Research Report 2024
Global Interleukin 17 Inhibitors Market Research Report 2024
Global Androgen Receptor AR Antagonist Market Research Report 2024
Global Biologics for Severe Asthma Market Research Report 2024
Global Neurokinin Receptor Antagonists Market Research Report 2024
Global Bradykinin Receptor Antagonists Market Research Report 2024
Global IL 6R Agonist Market Research Report 2024
Global CXCR4 Antagonists Market Insights Forecast to 2030
Global FLT3 Antagonists Market Research Report 2024
Global Biologics Targeting CCR4 Market Research Report 2024
Global Angiotensin II Type 1 Receptor AT1R Antagonists Market Research Report 2024
Global Interleukin 6 Inhibitors for Rheumatoid Arthritis Market Research Report 2024
Global VEGFR 2 Inhibitor Market Research Report 2024
Global P2X7 Receptor Antagonists Market Insights Forecast to 2030
Global GLP 1 Receptor Antagonist Market Research Report 2024
Global IL 17 Targeting Biological Drugs Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions